Company Filing History:
1 out of 64 
1 out of 154 
1 out of 1 Years Active: 2021-2024
Title: Tim Yen: Innovator in Cancer Treatment
Introduction
Tim Yen is a notable inventor based in Philadelphia, PA, who has made significant contributions to the field of cancer research. With a focus on innovative treatments, he holds two patents that address critical challenges in oncology. His work aims to improve the lives of cancer patients through advanced therapeutic methods.
Latest Patents
Tim Yen's latest patents revolve around the inhibition of thymine DNA glycosylase in the treatment of cancer. These inventions provide compositions, kits, and methods for inducing growth arrest, differentiation, or senescence of cancer cells that express thymine DNA glycosylase. The methods involve inhibiting the expression or biological activity of thymine DNA glycosylase in cancer cells. This inhibition may lead to the reversion of cancer cells to a healthy, non-cancerous phenotype or induce senescence. The types of cancer targeted by these methods include melanoma, lung, prostate, pancreatic, ovarian, brain, colon, recto-sigmoid colon, and breast cancer cells.
Career Highlights
Throughout his career, Tim Yen has worked with esteemed organizations such as the Institute for Cancer Research and Institut Curie. His experience in these institutions has allowed him to develop groundbreaking approaches to cancer treatment. His dedication to research and innovation has positioned him as a key figure in the fight against cancer.
Collaborations
Tim has collaborated with notable colleagues in the field, including Alfonso Bellacosa and Rossella Tricarico. These partnerships have fostered a collaborative environment that enhances the development of effective cancer therapies.
Conclusion
Tim Yen's contributions to cancer research through his innovative patents highlight his commitment to improving patient outcomes. His work continues to inspire advancements in the treatment of various types of cancer.